These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 35129813)

  • 1. Potential Role of Curcumin for the Treatment of Major Depressive Disorder.
    Lopresti AL
    CNS Drugs; 2022 Feb; 36(2):123-141. PubMed ID: 35129813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple antidepressant potential modes of action of curcumin: a review of its anti-inflammatory, monoaminergic, antioxidant, immune-modulating and neuroprotective effects.
    Lopresti AL; Hood SD; Drummond PD
    J Psychopharmacol; 2012 Dec; 26(12):1512-24. PubMed ID: 23035031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin for neuropsychiatric disorders: a review of in vitro, animal and human studies.
    Lopresti AL
    J Psychopharmacol; 2017 Mar; 31(3):287-302. PubMed ID: 28135888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of the Anxiolytic and Antidepressant Effects of Curcumin, a Compound From Turmeric (Curcuma longa), in the Adult Male Sprague-Dawley Rat.
    Ceremuga TE; Helmrick K; Kufahl Z; Kelley J; Keller B; Philippe F; Golder J; Padrón G
    Holist Nurs Pract; 2017; 31(3):193-203. PubMed ID: 28406873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin as a putative antidepressant.
    Seo HJ; Wang SM; Han C; Lee SJ; Patkar AA; Masand PS; Pae CU
    Expert Rev Neurother; 2015 Mar; 15(3):269-80. PubMed ID: 25644944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin for the treatment of major depression: a randomised, double-blind, placebo controlled study.
    Lopresti AL; Maes M; Maker GL; Hood SD; Drummond PD
    J Affect Disord; 2014; 167():368-75. PubMed ID: 25046624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin and nano-curcumin applications in psychiatric disorders.
    Mohammadzadeh R; Fathi M; Pourseif MM; Omidi Y; Farhang S; Barzegar Jalali M; Valizadeh H; Nakhlband A; Adibkia K
    Phytother Res; 2024 Aug; 38(8):4240-4260. PubMed ID: 38965868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of curcumin, and a saffron/curcumin combination for the treatment of major depression: A randomised, double-blind, placebo-controlled study.
    Lopresti AL; Drummond PD
    J Affect Disord; 2017 Jan; 207():188-196. PubMed ID: 27723543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A critical examination of studies on curcumin for depression.
    Andrade C
    J Clin Psychiatry; 2014 Oct; 75(10):e1110-2. PubMed ID: 25373119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of monoaminergic system contributes to the antidepressant- and anxiolytic-like effects of J147.
    Pan X; Chen L; Xu W; Bao S; Wang J; Cui X; Gao S; Liu K; Avasthi S; Zhang M; Chen R
    Behav Brain Res; 2021 Aug; 411():113374. PubMed ID: 34023306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Turmeric and Curcumin: From Traditional to Modern Medicine.
    Akaberi M; Sahebkar A; Emami SA
    Adv Exp Med Biol; 2021; 1291():15-39. PubMed ID: 34331682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review of the antidepressant effects of curcumin: Beyond monoamines theory.
    Matias JN; Achete G; Campanari GSDS; Guiguer ÉL; Araújo AC; Buglio DS; Barbalho SM
    Aust N Z J Psychiatry; 2021 May; 55(5):451-462. PubMed ID: 33673739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Comprehensive Review on the Therapeutic Potential of
    Fuloria S; Mehta J; Chandel A; Sekar M; Rani NNIM; Begum MY; Subramaniyan V; Chidambaram K; Thangavelu L; Nordin R; Wu YS; Sathasivam KV; Lum PT; Meenakshi DU; Kumarasamy V; Azad AK; Fuloria NK
    Front Pharmacol; 2022; 13():820806. PubMed ID: 35401176
    [No Abstract]   [Full Text] [Related]  

  • 14. Multitargeting by turmeric, the golden spice: From kitchen to clinic.
    Gupta SC; Sung B; Kim JH; Prasad S; Li S; Aggarwal BB
    Mol Nutr Food Res; 2013 Sep; 57(9):1510-28. PubMed ID: 22887802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Curcumin Administration in Patients with Major Depressive Disorder: Mini Meta-Analysis of Clinical Trials.
    Al-Karawi D; Al Mamoori DA; Tayyar Y
    Phytother Res; 2016 Feb; 30(2):175-83. PubMed ID: 26610378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental and clinical reports on anti-inflammatory, antioxidant, and immunomodulatory effects of Curcuma longa and curcumin, an updated and comprehensive review.
    Memarzia A; Khazdair MR; Behrouz S; Gholamnezhad Z; Jafarnezhad M; Saadat S; Boskabady MH
    Biofactors; 2021 May; 47(3):311-350. PubMed ID: 33606322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidotal or protective effects of Curcuma longa (turmeric) and its active ingredient, curcumin, against natural and chemical toxicities: A review.
    Hosseini A; Hosseinzadeh H
    Biomed Pharmacother; 2018 Mar; 99():411-421. PubMed ID: 29367110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin for depression: a meta-analysis.
    Fusar-Poli L; Vozza L; Gabbiadini A; Vanella A; Concas I; Tinacci S; Petralia A; Signorelli MS; Aguglia E
    Crit Rev Food Sci Nutr; 2020; 60(15):2643-2653. PubMed ID: 31423805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin, an active component of turmeric (Curcuma longa), and its effects on health.
    Kocaadam B; Şanlier N
    Crit Rev Food Sci Nutr; 2017 Sep; 57(13):2889-2895. PubMed ID: 26528921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin and major depression: a randomised, double-blind, placebo-controlled trial investigating the potential of peripheral biomarkers to predict treatment response and antidepressant mechanisms of change.
    Lopresti AL; Maes M; Meddens MJ; Maker GL; Arnoldussen E; Drummond PD
    Eur Neuropsychopharmacol; 2015 Jan; 25(1):38-50. PubMed ID: 25523883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.